AREDS2 stands for Age-Related Eye Disease Study 2, a clinical trial conducted by the National Eye Institute. The study found that a specific combination of vitamins and minerals could help reduce ...

Another key finding of the Age-Related Eye Disease Study 2, or AREDS 2, is that lutein and zeaxanthin may be safer than beta-carotene in reducing risk of disease progression. "If you look at all ...

Participants in the AREDS2 study took one of four AREDS2 supplement formulations identified as potentially beneficial in the AREDS study. Each participant took the supplement daily for five years.

“Patients who have age-related macular degeneration have a clear benefit to taking an antioxidant vitamin combination known as the Age-Related Eye Diseases Study (AREDS) 2 formula,” notes Adrienne ...

A new study from the National Eye Institute has found that eating foods high in dietary nitrates—mainly from vegetables—may ...

Inspired by the AREDs-2 study and enriched with antioxidant-rich plant extracts like bilberry, turmeric, saffron, and ginkgo biloba, iGenics targets the root causes of declining vision—oxidative ...

At the end of the five-year AREDS2 study period, the researchers concluded that lutein and zeaxanthin did not increase risk for lung cancer, and that the new formation could reduce the risk of AMD ...

The benefits of the formulation were confirmed in the National Eye Institute’s Age-Related Eye Disease Study (AREDS 2) study, which followed 3,883 individuals with moderate to advanced AMD over ...

Another smart move, especially for those with wet stage AMD, according to the National Eye Institute AREDs 2 study: Slow progression of dry AMD with a daily supplement formula. The supplements ...